-
Dr. Catalina Morales-Alvarez is an Assistant Professor in the Division of Nephrology at the University of Alabama at Birmingham. Her academic and clinical interests include home dialysis, nephrolithiasis, palliative care and conservative management in advanced kidney disease, and improving kidney care access and outcomes in underserved communities, particularly Latino populations. She is actively involved in medical education and fellowship mentorship. Dr. Gabrielle Barthel is a recent [...]
-
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the November 2026 issue: Lived Experiences of Home-Based Conservative Kidney Management in Older Adults: A Qualitative Study by [...]
-
The prevalence of anemia is high in people with chronic kidney disease (CKD) and increases as the disease advances. The Kidney Disease Outcomes Quality Initiative (KDOQI) convened a work group to review the Kidney Disease: Improving Global Outcomes (KDIGO) 2026 clinical practice guideline for the management of anemia in CKD. A recent KDOQI Commentary by Jalal et al in AJKD presents recommendations and practice points from the KDIGO guideline, followed by a commentary and brief notes on [...]
-
In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial team. We continue the tradition this year by inducting six remarkable reviewers into the AJKD Reviewer Hall of Fame. The editors thank and congratulate these reviewers, all of whom shared why they participate in the peer review process below: Emmanuel Adomako, MD @EAAdomako.bsky.social | @EAAdomako University of [...]
-
It’s Kidney Week 2026! As many of you gather in Denver, we at the AJKDblog observe a tradition as old as time (or at least 2018); unveiling the logo for #NephMadness 2027. Our thanks as always to Graham Gipson @grahamgipsonmd for the design (check out his work from 2022, 2023, 2024, 2025, and 2026). SAVE THE DATE: NephMadness will begin on March 1, 2027! While you anticipate NephMadness 2027, check out this slideshow of past NephMadness logos: NephMadness | [...]
Follow Blog by Email:
NephMadness 2026
-
NephMadness#NephMadness 2026: IgA Nephropathy Region
-
NephMadness#NephMadness 2026: Call for Topic Suggestions
-
NephMadness#NephMadness 2026: POCUS – Stop Guessing, Start Scanning
-
NephMadnessA Look Back at Top #NephMadness Regions
-
NephMadness#NephMadness 2026: Trolls of Transplantation Region
-
NephMadness#NephMadness 2026: Thank You
-
NephMadness#NephMadness 2026: A future so bright you gotta wear shades – B-cell modulating therapies in IgAN
-
NephMadness#NephMadness 2026 Champion: B-Cell Modulators
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 2
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology: Light Chain Cast Nephropathy
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: Sampling Error in Misdiagnosis
-
Atlas of Renal Pathology IIDiffuse Mesangial Sclerosis
-
Atlas of Renal Pathology IIPractical Tips for the Diagnosis of Acute Antibody-Mediated Rejection
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology II: The Ultimate Pathology Teaching Tool Has Arrived
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 3
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 5
-
Atlas of Renal Pathology IIRecurrent and De novo Posttransplant Minimal Change Disease
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology: Cholesterol Emboli
Follow Blog by Email:
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy






